Fate Therapeutics FATE Insider Ownership

NASDAQ FATE

$2.06 +0.20 (+10.75%)

At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

15.72Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

12.78%

▼-0.069% pp QoQ

Shares Held by Insiders

15.38Mn

filed for Sep 2026

▼-0.53% QoQ

Shares Outstanding

120.40Mn

120,397,390 shares

Direct Holdings

2.04Mn

Indirect: 13.34Mn

Net Shares Traded (QoQ)

-82.75K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the past year, FATE insiders sold $322,905 of stock (153.06K shares) on the open market and bought none.

A count shows 2 insiders selling FATE stock on the open market over the past 12 months and none buying.
Bahram Valamehr (President and CEO) was FATE's largest open-market seller in the past 12 months, with $168,140 of sales (78.08K shares); the latest was on August 4, 2026.
In transactions other than open-market trades, Fate Therapeutics insiders received 535K shares in stock awards and acquired 191.66K shares through option exercises and conversions over the past 12 months.
Business Quant data puts insider holdings in FATE at 15.38Mn shares across insiders' latest Form 4 filings, down 0.53% from 15.47Mn shares at the end of Q2 2026 and up 0.82% from 15.26Mn shares at the end of Q3 2025.
Of the 15.38Mn shares held by Fate Therapeutics insiders, 2.04Mn shares (13.26%) are held directly and 13.34Mn shares (86.74%) indirectly, through trusts, partnerships, family members and other entities.
Per Business Quant, 12 insiders of FATE hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
FATE's three largest insider shareholders, per their latest Form 4 filings, are Redmile Group, LLC (Director and 10% owner, 12.88Mn shares), Bahram Valamehr (President and CEO, 591.82K shares) and Cindy Tahl (Officer, 589.36K shares).
The holding of Redmile Group, LLC makes up 83.75% of all shares held by Fate Therapeutics insiders.
Institutional investors held 59.28% of Fate Therapeutics stock at the end of Q2 2026, while the latest Form 4 filings of its insiders account for about 12.78%; other investors, including the public, hold roughly 27.94%.
In the last 12 months, 24 Form 4 filings with transactions in FATE stock came from 12 insiders.
Insider figures for FATE include Form 4 filings through August 5, 2026.

Form 4 Holdings

Insiders Holding FATE

Insiders 19

Shares held 15.72Mn

Of outstanding 13.06%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Group, Llc Redmile	Director, TenPercentOwner	0	12,884,277	12,884,277	81.9%	22 Apr, 2026
2	Bahram Valamehr	President And Ceo	591,815	0	591,815	3.8%	05 Aug, 2026
3	Cindy Tahl	General Counsel And Secretary	589,355	0	589,355	3.7%	05 Aug, 2026
4	J Scott Wolchko	President And Ceo	371,248	0	371,248	2.4%	10 Jan, 2024
5	Jerome Charles Bressi	Officer	335,203	0	335,203	2.1%	16 Jan, 2025
6	John Mendlein	Director	311,231	0	311,231	2.0%	20 Jan, 2023
7	Yu-Waye Chu	Chief Medical Officer	140,676	0	140,676	0.9%	19 Apr, 2023
8	Mark Plavsic	Chief Technical Officer	123,705	0	123,705	0.8%	11 Jan, 2023
9	Edward J Iii Dulac	Chief Financial Officer	101,479	0	101,479	0.6%	05 Mar, 2024
10	Kamal Adawi	Chief Financial Officer	100,000	0	100,000	0.6%	16 Jan, 2026
11	Brian T. Powl	Chief Commercial Officer	41,146	0	41,146	0.3%	06 Jul, 2023
12	William H Rastetter	Director	36,331	0	36,331	0.2%	06 May, 2026
13	Robert S Epstein	Director	36,331	0	36,331	0.2%	06 May, 2026
14	Michael Stewart Lee	Director	11,331	0	11,331	0.1%	13 Jun, 2022
15	Robert Hershberg	Director	10,659	0	10,659	0.1%	13 Jun, 2022
16	Shefali Agarwal	Director	10,490	0	10,490	0.1%	13 Jun, 2022
17	Timothy Coughlin	Director	9,892	0	9,892	0.1%	13 Jun, 2022
18	Karin Jooss	Director	9,848	0	9,848	0.1%	13 Jun, 2022
19	Yuan Xu	Director	8,669	0	8,669	0.1%	07 Aug, 2024

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

985 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
04 Aug, 2026	Bahram Valamehr	President And Ceo	Disposed S	43,947	$2.46	$108.10K	591,815	Direct
04 Aug, 2026	Cindy Tahl	Officer	Disposed S	38,800	$2.46	$95.41K	589,355	Direct
12 Jun, 2026	Matt Abernethy	Director	Acquired A	87,900	$0.00	$0	87,900	Direct
12 Jun, 2026	Group, Llc Redmile	Director, TenPercentOwner	Acquired A	87,900	$0.00	$0	87,900	Indirect
12 Jun, 2026	Yuan Xu	Director	Acquired A	87,900	$0.00	$0	87,900	Direct
12 Jun, 2026	William H Rastetter	Director	Acquired A	87,900	$0.00	$0	87,900	Direct
12 Jun, 2026	Laura Hamill	Director	Acquired A	175,800	$0.00	$0	175,800	Direct
12 Jun, 2026	Karin Jooss	Director	Acquired A	87,900	$0.00	$0	87,900	Direct
12 Jun, 2026	Robert S Epstein	Director	Acquired A	87,900	$0.00	$0	87,900	Direct
12 Jun, 2026	Michael Stewart Lee	Director	Acquired A	87,900	$0.00	$0	87,900	Direct
12 Jun, 2026	Shefali Agarwal	Director	Acquired A	87,900	$0.00	$0	87,900	Direct
20 May, 2026	Bahram Valamehr	President And Ceo	Disposed S	28,946	$1.88	$54.48K	635,762	Direct
20 May, 2026	Cindy Tahl	Officer	Disposed S	25,590	$1.88	$48.08K	628,155	Direct
06 May, 2026	Cindy Tahl	Officer	Acquired M	122,220	$1.32	$161.33K	609,301	Direct
06 May, 2026	Cindy Tahl	Officer	Acquired M	44,444	$1.05	$46.67K	653,745	Direct
06 May, 2026	Cindy Tahl	Officer	Disposed M	122,220	$0.00	$0	152,780	Direct
06 May, 2026	Cindy Tahl	Officer	Disposed M	44,444	$0.00	$0	355,556	Direct
05 May, 2026	William H Rastetter	Director	Acquired M	25,000	$1.69	$42.25K	36,331	Direct
05 May, 2026	Robert S Epstein	Director	Acquired M	25,000	$1.69	$42.25K	36,331	Direct
05 May, 2026	Robert S Epstein	Director	Acquired M	25,000	$0.00	$0	0	Direct

Showing 1 to 20 of 985 transactions